Shengfeng Wang-全球最大的赌钱网(中国)有限公司

Faculty

Current Location: English Home > Faculty > Department of Epidemiology and Biostatistics > Shengfeng Wang

Shengfeng Wang

Assistant Professor
wangshengfeng@bjmu.edu.cn
Xueyuan Road 38, Haidian District, Beijing, China
Peking University

Personal profile

Dr. Wang gained the bachelor degree of Medicine in 2007, and received his PhD in Epidemiology and Bio-statistics at Peking University in 2012. Dr. Wang worked as a visiting scholar in Pritzker school of Medicine, University of Chicago during 2015-2017. As a principal investigator, he has leaded 12 projects, which were funded by the Ministry of Science and Technology of China, the Premier fund project, National Natural Science Foundation, the Special Fund of the Ministry of Health Public Service Sectors, etc. And he has also participated in more than 10 national projects, including the Ministry of Science and Technology of China, National Natural Science Foundation, etc. He has published more than 120 papers, including JAMA Network Open (13.360)，Lancet HIV (16.070)，Plos Medicine (11.069)，Journal of Neurology, Neurosurgery & Psychiatry (10.283)，Asian journal of psychiatry (13.890), etc. He is the member of Committee of Pharmaco-epidemiology of Chinese Pharmaceutical Association, Secretary-general of the evidence-based evaluation committee of Beijing cancer prevention and treatment society, Member of Committee of Big Data Branch of Beijing Society of Chronic Disease Prevention and Health Education, Office director of Center of Post-marketing Safety Evaluation of Peking University Health Science Center, etc. He has awarded first prize of National Hybrid Instructional Design Innovation Competition, Peking University Zhongwai Medical Award, Peking University Zheng Da Award, Peking University Excellent Teaching Award, First prize of Beijing Young Teachers Teaching Skills Competition, etc.

Main research directions

Non-communicable Disease (NCD) Epidemiology, particularly cancer

Pharmaco-epidemiology

Rare disease epidemiology

Utilization of big data in health care

Representative scientific research projects

1. Construction of cohort and data platform for research about urinary function of the elderly patients, supported by National key research and development program, 2022~2025, Sub-investigator.

2. Capital Health Development Research Project, Prostate Cancer Precision Screening and Health Economics Evaluation in Beijing, Co-principal

3. Risk assessment technology and prevention strategy of occupational hazard emergencies in power grid Corporation, supported by State Grid Corporation of China (State Grid), 2021-2022, Sub-investigator.

4. A feasibility evaluation on real world study for traditional Chinese medicine based on healthcare big data, supported by The Institute of Culture Inheritance and Innovation, Peking University, 2020-2021, Principal investigator.

5. The comparison analysis on different countries’ policy about post-marketing safety study, supported by National Medical Products Administration, 2020-2021, Principal investigator.

6. The study on the pattern and safety of psychiatric medication in senile dementia patients based on claim data, supported by Foundation of Peking University Youth Technology Innovation Platform, 2020-2021, Principal investigator.

7. The study of data collection standards and sharing mechanism of population based cancer registry data and clinical data, supported by National key research and development program, 2018~2020, Sub-investigator.

8. National research program for key issues in air pollution, supported by Premier fund project, 2017-2019, Sub-investigator.

9. An exploratory study on the scientific research innovation capacity index of Beijing tertiary hospitals, supported by Beijing Research Center of Urban System Engineering, 2017~2018, Principal investigator.

10. A methodology study of control selection in electronic medical records-based safety surveillance, supported by National Natural Science Foundation of China, 2016~2018, Principal investigator.

10 representative papers

1. Zhou Huziwei#, Qiao Liying#, Zhang Yunjing, Kang Weiwei, Yan xue, Jiang Yuling, Ke Yalei, Rao Yingting, Liu Guozhen, Wang Mingyuan, Wang Hui, Xi Yunfeng*, Wang Shengfeng*. Association of Ethnicity, Sex, and Age With Cancer Diagnoses and Health Care Utilization Among Children in Inner Mongolia, China. JAMA Network Open. 2022, 5(9):e2231182. (IF = 13.360)

2. Chen Fangfang#, Cai Chang#, Wang Shengfeng#, Qin Qianqian, Jin Yichen , Li Dongmin, Ge Lin, Li Peilong, Cui Yan, Tang Houlin*, Lv Fan*.Trends in suicide mortality among people with HIV after diagnosis during 2012-18: a retrospective, national cohort study in China. Lancet HIV. 2022, 9(2):e102-e111. (IF = 16.070)

3. Xu Lu#, Kang Weiwei#, Qiao Liying, Ren Jing, Liu Guozhen, Wang Shengfeng*, Xi Yunfeng*, Zhan Siyan*. Suicides among cancer patients in Inner Mongolia Autonomous Region: A population-based study. Asian journal of psychiatry, 2022, 78, 103291. (IF = 13.890)

4. Zhang Chenggui#, Feng Jingnan#, Wang Shengfeng#, Gao Pei#, Xu Lu, Zhu Junxiong, Jia Jialin, Liu Lili, Liu Guozhen, Wang Jinxi, Zhan Siyan*, Song Chunli*; Incidence of and trends in hip fracture among adults in urban China: a nationwide retrospective cohort study. PLOS Medicine, 2020, 17(8):e1003180. (IF = 11.069)

5. Xu Lu#; Chen Lu#; Wang Shengfeng#; Feng Jingnan; Liu Lili; Liu Guozhen; Wang Jinxi; Zhan Siyan*; Gao Pei; Fan Dongsheng; Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study, Journal of Neurology, Neurosurgery, and Psychiatry, 2020, 91:520-525. (IF =10.283，入选中国2020年度重要医学进展)

6. Sun Yixin#, Zhou Guoyu#, Feng Jingnan, Chen Lu, Liu Gguozhen, Wang Jinxin, Wang Qingliang, Yu Junyou, Yang Xiwang, Yang Zheng, Gao Pei*, Wang Shengfeng*, Zhan Siyan*. Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study. Stroke and vascular neurology,2021, 6(4), 615–623. (IF = 9.893)

7. Liu Tanxin; Song Yongfeng; Chen Ru; Zheng Rongshou; Wang Shengfeng*; Li Liliming*; Solid fuel use for heating and risks of breast and cervical cancer mortality in China. Environmental research. 2020, 186:109578. (IF = 6.498)

8. Feng Jingnan#, Sun Lina#, Sun Xiaoyan, Xu Lu, Liu Lili, Liu Guozhen, Wang Jinxin, Gao Pei, Zhan Siyan*, Chen Yahong*, Wang Shengfeng*, Sun Yongchang*. Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013-2017: a nationwide population-based cohort study. Respiratory research, 2022,23(1), 111 (IF = 7.162)

9. Wang Shengfeng, Huo D, Kupfer S, Alleyne D, Ogundiran TO, Ojengbede O, Zheng W, NathansonKL,Nemesure B, Ambs S, Olopade OI*, Zheng Y*; Genetic variation in the Vitamin D related pathway and breast cancer risk in women of African ancestry in the Root Consortium, International Journal of Cancer, 2018, 142(1):36-43. (IF = 7.360)

10. Wang Shengfeng, OgundiranT, AdemolaA, OlayiwolaOA, Adeoye A, Sofoluwe A, Morhason-BelloI, OdedinaS, AgwaiI, AdebamowoC, ObajimiM, Ojengbede O, Olopade OI*, Huo D*; Development of a Breast Cancer Risk Prediction Model for Women in Nigeria, Cancer Epidemiology, Biomarkers & Prevention, 2018. (IF = 5.057)